Clifford Swan Investment Counsel Llc
Source: SEC Form 13F · as of Mar 2026Clifford Swan Investment Counsel Llc holds 20 biotech & pharma companies tracked by BioSniper, totaling $282.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$282.6M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 211,196 | $51.6M |
| ABBVAbbVie Inc. | 146,672 | $31.9M |
| MCKMcKesson Corporation | 36,643 | $31.7M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 111,352 | $30.1M |
| ABTABBOTT LABORATORIES | 201,299 | $20.7M |
| BMYBRISTOL MYERS SQUIBB CO | 301,465 | $18.3M |
| ZTSZoetis Inc. | 148,151 | $17.5M |
| PMPhilip Morris International Inc | 94,642 | $15.6M |
| PFEPFIZER INC | 489,295 | $13.7M |
| AMGNAMGEN INC | 37,189 | $13.1M |
| NVONovo Nordisk A/S | 324,741 | $11.9M |
| NVSNovartis AG | 72,551 | $11.1M |
| MRKMerck & Co., Inc. | 76,120 | $9.2M |
| LLYELI LILLY & Co | 3,416 | $3.1M |
| GILDGILEAD SCIENCES, INC. | 11,913 | $1.7M |
| ZBHZimmer Biomet Holdings Inc. | 4,412 | $399K |
| GMOptec International, Inc. | 3,489 | $260K |
| CAHCardinal Health Inc. | 1,187 | $251K |
| GEHCGE HealthCare Technologies Inc. | 2,989 | $213K |
| AZNASTRAZENECA PLC | 1,034 | $204K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.